165 related articles for article (PubMed ID: 35962451)
1. Identification of LARS as an essential gene for osteosarcoma proliferation through large-Scale CRISPR-Cas9 screening database and experimental verification.
Chen W; Lin Y; Jiang M; Wang Q; Shu Q
J Transl Med; 2022 Aug; 20(1):355. PubMed ID: 35962451
[TBL] [Abstract][Full Text] [Related]
2. Screening and identification of CNIH4 gene associated with cell proliferation in gastric cancer based on a large-scale CRISPR-Cas9 screening database DepMap.
Zhang H; Lin Y; Zhuang M; Zhu L; Dai Y; Lin M
Gene; 2023 Jan; 850():146961. PubMed ID: 36220450
[TBL] [Abstract][Full Text] [Related]
3. CRISPR-Cas9 screening identified lethal genes enriched in necroptosis pathway and of prognosis significance in osteosarcoma.
Cheng L; Xiong W; Li S; Wang G; Zhou J; Li H
J Gene Med; 2023 Dec; 25(12):e3563. PubMed ID: 37421290
[TBL] [Abstract][Full Text] [Related]
4. Systematic screening for potential therapeutic targets in osteosarcoma through a kinome-wide CRISPR-Cas9 library.
Wu Y; Zhou L; Wang Z; Wang X; Zhang R; Zheng L; Kang T
Cancer Biol Med; 2020 Aug; 17(3):782-794. PubMed ID: 32944406
[No Abstract] [Full Text] [Related]
5. CRISPR-cas9 screening identified lethal genes enriched in Hippo kinase pathway and of predictive significance in primary low-grade glioma.
Mijiti M; Maimaiti A; Chen X; Tuersun M; Dilixiati M; Dilixiati Y; Zhu G; Wu H; Li Y; Turhon M; Abulaiti A; Maimaitiaili N; Yiming N; Kasimu M; Wang Y
Mol Med; 2023 May; 29(1):64. PubMed ID: 37183261
[TBL] [Abstract][Full Text] [Related]
6. Identification of NCAPG as an Essential Gene for Neuroblastoma Employing CRISPR-Cas9 Screening Database and Experimental Verification.
Jia Y; Yang J; Chen Y; Liu Y; Jin Y; Wang C; Gong B; Zhao Q
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834394
[TBL] [Abstract][Full Text] [Related]
7. Identification of UBE2I as a Novel Biomarker in ccRCC Based on a Large-Scale CRISPR-Cas9 Screening Database and Immunohistochemistry.
Li F; Lai L; You Z; Cheng H; Guo G; Tang C; Xu L; Liu H; Zhong W; Lin Y; Wang Q; Lin Y; Wei Y
Front Mol Biosci; 2022; 9():813428. PubMed ID: 35211510
[No Abstract] [Full Text] [Related]
8. Essential genes analysis reveals small ribosomal subunit protein eS28 may be a prognostic factor and potential vulnerability in osteosarcoma.
Liang C; Zhou J; Wang Y; Sun Y; Zhou J; Shao L; Zhang Z; Yan W; Liu Z; Dong Y
J Bone Oncol; 2024 Feb; 44():100517. PubMed ID: 38204480
[TBL] [Abstract][Full Text] [Related]
9. CRISPR-cas9 Screening Identified Lethal Genes Enriched in Cell Cycle Pathway and of Prognosis Significance in Breast Cancer.
Sun X; Wang Z; Chen X; Shen K
Front Cell Dev Biol; 2021; 9():646774. PubMed ID: 33816496
[TBL] [Abstract][Full Text] [Related]
10. Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance.
Liu T; Li Z; Zhang Q; De Amorim Bernstein K; Lozano-Calderon S; Choy E; Hornicek FJ; Duan Z
Oncotarget; 2016 Dec; 7(50):83502-83513. PubMed ID: 27835872
[TBL] [Abstract][Full Text] [Related]
11. SFPQ promotes the proliferation, migration and invasion of hepatocellular carcinoma cells and is associated with poor prognosis.
Lin Y; Zhong W; Lin Q; Ye Y; Li S; Chen H; Liu H; Xu L; Zhuang W; Chen S; Lin Y; Wang Q
Am J Cancer Res; 2023; 13(6):2269-2284. PubMed ID: 37424798
[TBL] [Abstract][Full Text] [Related]
12. Applications of CRISPR/Cas9 in the research of malignant musculoskeletal tumors.
Liu W; Wang S; Lin B; Zhang W; Ji G
BMC Musculoskelet Disord; 2021 Feb; 22(1):149. PubMed ID: 33546657
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and prognostic value of potential dependency genes in clear cell renal cell carcinoma based on a large-scale CRISPR-Cas9 and RNAi screening database DepMap.
Shi B; Ding J; Qi J; Gu Z
Int J Med Sci; 2021; 18(9):2063-2075. PubMed ID: 33850477
[TBL] [Abstract][Full Text] [Related]
14. Role of miRNA-542-5p in the tumorigenesis of osteosarcoma.
Zhu T; Fan D; Ye K; Liu B; Cui Z; Liu Z; Tian Y
FEBS Open Bio; 2020 Apr; 10(4):627-636. PubMed ID: 32105410
[TBL] [Abstract][Full Text] [Related]
15. High Expression of N-Acetylgalactosaminyl-transferase 1 (GALNT1) Associated with Invasion, Metastasis, and Proliferation in Osteosarcoma.
Zhang L; Lv B; Shi X; Gao G
Med Sci Monit; 2020 Dec; 26():e927837. PubMed ID: 33284788
[TBL] [Abstract][Full Text] [Related]
16. Sox2 is required for tumor development and cancer cell proliferation in osteosarcoma.
Maurizi G; Verma N; Gadi A; Mansukhani A; Basilico C
Oncogene; 2018 Aug; 37(33):4626-4632. PubMed ID: 29743593
[TBL] [Abstract][Full Text] [Related]
17. Upregulated LEPRE1 correlates with poor outcome and its knockdown attenuates cells proliferation, migration and invasion in osteosarcoma.
Huang Z; Wang Q; Wang Y; Zhao L; Cao Z; Cui C; Yu D; Liu B
Anticancer Drugs; 2020 Apr; 31(4):326-332. PubMed ID: 32197005
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of TBRG4 suppresses proliferation, invasion and promotes apoptosis of osteosarcoma cells by downregulating TGF-β1 expression and PI3K/AKT signaling pathway.
Huang F; Zhou P; Wang Z; Zhang XL; Liao FX; Hu Y; Chang J
Arch Biochem Biophys; 2020 Jun; 686():108351. PubMed ID: 32240636
[TBL] [Abstract][Full Text] [Related]
19. CBX3 predicts an unfavorable prognosis and promotes tumorigenesis in osteosarcoma.
Ma C; Nie XG; Wang YL; Liu XH; Liang X; Zhou QL; Wu DP
Mol Med Rep; 2019 May; 19(5):4205-4212. PubMed ID: 30942427
[TBL] [Abstract][Full Text] [Related]
20. Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells.
Liao Y; Chen L; Feng Y; Shen J; Gao Y; Cote G; Choy E; Harmon D; Mankin H; Hornicek F; Duan Z
Oncotarget; 2017 May; 8(18):30276-30287. PubMed ID: 28415820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
